What Is BPC-157? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. BPC-157 is not FDA-approved for human therapeutic use, and products sold online may carry quality, safety, and regulatory risks.
Quick answer
BPC-157 is a synthetic peptide, also called Body Protection Compound-157, derived from a sequence associated with a protein found in gastric juice. It has been studied mostly in animal and laboratory models for wound healing, tendon and ligament repair, gastrointestinal protection, inflammation, and blood-vessel-related healing pathways. The strongest evidence for BPC-157 is preclinical, not clinical. It is not FDA-approved, has very limited human safety data, and is prohibited in competitive sport under WADA rules.
Key facts about BPC-157
| Question | Answer |
|---|---|
| What is BPC-157? | A synthetic 15-amino-acid peptide studied for tissue repair and gastrointestinal protection. |
| Other names | Body Protection Compound-157, PL 14736, stable gastric pentadecapeptide BPC 157. |
| Peptide class | Experimental repair peptide / gastric pentadecapeptide. |
| Main mechanism | Proposed effects on angiogenesis, nitric oxide pathways, tendon fibroblast migration, inflammation, and tissue repair signaling. |
| Main studied uses | Wound healing, tendon and ligament injury, muscle injury, gastrointestinal injury, inflammation, and vascular repair models. |
| FDA-approved? | No. BPC-157 is not an FDA-approved drug. |
| Human evidence level | Very limited. One small 2025 pilot safety study involved only 2 healthy adults. |
| Animal evidence level | Substantial preclinical literature, especially in tissue injury and gastrointestinal models. |
| Common online claims | “Heals injuries,” “repairs tendons,” “reduces inflammation,” “fixes gut issues,” “accelerates recovery.” |
| Sports status | Prohibited by WADA under S0 Unapproved Substances. |
| Main safety concern | Lack of robust human data, unknown long-term safety, immunogenicity risk, peptide impurities, API characterization, and unregulated online products. |
What is BPC-157?
BPC-157 is a synthetic peptide made of 15 amino acids. It is commonly described in scientific literature as a “stable gastric pentadecapeptide,” meaning it is a 15-amino-acid peptide associated with gastric biology and studied for protective effects in experimental injury models.
Researchers have examined BPC-157 in relation to gastrointestinal lesions, wound healing, tendon healing, ligament healing, muscle injury, bone injury, blood vessel function, and inflammatory injury models.
The important distinction is this:
BPC-157 is biologically interesting, but it is not an approved medicine. A peptide can show promising effects in animal or cell studies without being proven safe or effective for human therapeutic use. The FDA lists compounded BPC-157 among substances that may pose significant safety risks because of limited safety information, immunogenicity concerns, peptide-related impurities, and active pharmaceutical ingredient characterization issues.
How does BPC-157 work?
BPC-157 is proposed to influence several healing-related pathways. Studies have investigated its effects on tendon fibroblast migration, cell survival under stress, angiogenesis, nitric oxide signaling, gastrointestinal integrity, and tissue repair after injury.
One tendon-healing study found that BPC-157 promoted tendon fibroblast outgrowth, survival, and migration, likely involving the FAK-paxillin signaling pathway.
Other research has focused on BPC-157 and nitric oxide signaling, vascular integrity, and angiogenesis. These mechanisms are part of why BPC-157 is often marketed for injury recovery, gut health, and inflammation.
But mechanism is not proof.
A proposed biological mechanism does not prove that BPC-157 heals injuries in humans, repairs tendons in humans, treats inflammatory disease, or safely accelerates recovery. The quality of evidence depends on controlled human studies, not just animal models, cell studies, or plausible pathways.
What is BPC-157 used for?
BPC-157 is commonly discussed for injury recovery, tendon repair, gut health, joint pain, inflammation, and general “healing.” The evidence quality varies sharply by claim.
| Use | Evidence level | What is known | What is not known |
|---|---|---|---|
| Tendon healing | Preclinical | Animal and cell studies suggest effects on tendon fibroblast migration, survival, and healing pathways. | Whether it reliably improves tendon healing in humans is not established. |
| Ligament injury | Preclinical | Reviews describe positive findings in animal ligament injury models. | No strong human clinical evidence supports routine therapeutic use. |
| Muscle injury | Preclinical | Animal studies suggest possible repair effects in injured muscle models. | Human benefit, dosing, and long-term safety are unclear. |
| Gut protection | Preclinical | BPC-157 has been studied in gastrointestinal lesion and gastric integrity models. | Human therapeutic benefit for gut disorders is not proven. |
| Wound healing | Preclinical | Reviews describe effects in wound-healing and tissue-injury models. | Human efficacy remains uncertain. |
| Anti-inflammatory effects | Preliminary / preclinical | Some studies suggest anti-inflammatory or tissue-protective effects. | Clinical relevance in humans is not established. |
| Anti-aging / performance | Unsupported | Often marketed by clinics and influencers. | No strong clinical evidence supports anti-aging or performance claims. |
What does the research show?
Human evidence
The human evidence for BPC-157 is very limited.
A 2025 pilot study reported that intravenous infusion of up to 20 mg of BPC-157 in 2 healthy adults showed no adverse effects and was well tolerated. That is useful as a tiny safety signal, but it is not enough to establish long-term safety, therapeutic benefit, optimal dosing, or efficacy for injuries, gut conditions, inflammation, or recovery.
This matters because many online claims imply that BPC-157 is clinically proven. That is misleading. A 2-person safety pilot is not proof that BPC-157 works for tendon repair, ligament injury, gut healing, or chronic pain in real-world human patients.
Animal and laboratory evidence
The preclinical evidence is much larger. Reviews and studies describe BPC-157 effects across tendon, ligament, muscle, bone, wound, gastrointestinal, vascular, and nervous-system injury models.
The strongest interpretation is:
BPC-157 has an unusually broad preclinical literature, but most of the evidence is not high-quality human clinical evidence.
Animal and lab studies can justify further research. They do not justify treating BPC-157 as a proven human therapy.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “BPC-157 helps tendon healing.” | Plausible but not proven in humans | Tendon studies show promising cell and preclinical findings, including fibroblast migration and FAK-paxillin signaling. Human efficacy is not established. |
| “BPC-157 repairs ligaments.” | Preclinical | Reviews describe ligament-related healing models, but human clinical evidence is lacking. |
| “BPC-157 heals the gut.” | Preclinical | It has been studied in gastric and gastrointestinal injury models. Human therapeutic use is not proven. |
| “BPC-157 reduces inflammation.” | Preliminary | Some mechanisms suggest anti-inflammatory or protective effects, but broad human claims are unsupported. |
| “BPC-157 accelerates injury recovery.” | Unproven in humans | This is the most common marketing claim, but controlled human evidence is weak. |
| “BPC-157 is safe because no one reports side effects.” | Misleading | FDA says safety information is limited and that compounded BPC-157 may pose immunogenicity and impurity-related risks. |
| “BPC-157 is FDA-approved.” | False | BPC-157 is not FDA-approved for human therapeutic use. |
| “BPC-157 is legal because it is sold online.” | Misleading | Online availability does not mean FDA approval or legal therapeutic sale. |
| “BPC-157 is allowed for athletes.” | False | WADA prohibits BPC-157 under S0 Unapproved Substances. |
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for human therapeutic use.
The FDA states that compounded drugs containing BPC-157 may pose safety risks related to immunogenicity, peptide impurities, API characterization, and limited safety information. FDA also says it lacks sufficient information to know whether BPC-157 would cause harm when administered to humans.
This is one of the most important facts for readers:
BPC-157 being sold online does not mean it is FDA-approved, legally marketed as a drug, or proven safe for human use.
Is BPC-157 legal?
The legal answer is not simple, but the practical answer is clear:
BPC-157 is not an FDA-approved drug, food, or dietary supplement ingredient in the United States.
USADA has stated that there appears to be no legal basis for selling BPC-157 as a drug, food, or dietary supplement, and that athletes should be aware it is being included in some wellness and anti-aging products.
The blunt version:
If a company is selling BPC-157 directly to consumers as a healing treatment, recovery peptide, anti-aging drug, or supplement, that should raise a red flag.
Is BPC-157 banned in sports?
Yes. BPC-157 is prohibited by WADA under the S0 Unapproved Substances category.
The WADA 2022 Prohibited List update specifically noted that BPC-157 was added as an example under section S0, Non-approved Substances.
The USADA BPC-157 athlete advisory also says BPC-157 is prohibited and not approved for human clinical use by any global regulatory authority.
For athletes, the answer is simple:
Do not use BPC-157 if you are subject to anti-doping rules.
Safety and side effects
The main safety issue with BPC-157 is not that it has been proven dangerous in large human trials. The issue is that it has not been adequately studied in humans.
Known or reported concerns include:
- Limited human safety data
- Unknown long-term effects
- Injection-site risks if injected
- Possible immunogenicity concerns
- Peptide impurity and product-quality risks
- Unclear safety across different routes of administration
- Lack of standardized human dosing
- Potential contamination, mislabeling, or incorrect concentration in online products
FDA specifically highlights potential immunogenicity, peptide-related impurities, and API characterization issues for compounded BPC-157. FDA also says it lacks sufficient information to know whether BPC-157 would cause harm when administered to humans.
A tiny 2025 human pilot safety study involving 2 healthy adults reported no adverse effects from intravenous BPC-157 infusion up to 20 mg, but that study is far too small to establish broader safety.
BPC-157 vs similar peptides
| Compound | Category | Main difference |
|---|---|---|
| BPC-157 | Experimental repair peptide | Mostly studied for tissue repair, gut protection, and injury models. |
| TB-500 | Thymosin beta-4 fragment-related peptide | Commonly marketed for repair and recovery, also surrounded by regulatory and evidence concerns. |
| CJC-1295 | GHRH analog | Designed to raise growth hormone and IGF-1, not primarily a repair peptide. |
| Ipamorelin | Growth hormone secretagogue | Stimulates growth hormone release through ghrelin receptor pathways. |
| GHK-Cu | Copper peptide | Often marketed for skin, hair, wound healing, and cosmetic uses. |
The key distinction:
BPC-157 is usually marketed as a tissue-repair peptide, while CJC-1295 and ipamorelin are usually marketed as growth-hormone-related peptides.
Why is BPC-157 sold as “research use only”?
Many online sellers label BPC-157 as “research use only” because it is not FDA-approved as a consumer therapeutic product. That label does not make it safe. It also does not mean it has been clinically proven.
“Research use only” usually means the product is being sold outside normal approved-drug channels. FDA and anti-doping authorities have warned about BPC-157 appearing in wellness, anti-aging, and performance products despite lacking approval for human clinical use.
A serious reader should treat “research use only” as a warning sign, not a trust signal.
How to evaluate BPC-157 claims online
| Claim | What to verify |
|---|---|
| “Clinically proven” | Was the claim tested in controlled human trials, or only animal/cell studies? |
| “FDA compliant” | Does that mean FDA-approved? Usually no. |
| “Third-party tested” | Is there a recent batch-specific COA with HPLC and LC-MS data? |
| “99% purity” | Was purity independently verified, and does the COA match the batch being sold? |
| “Doctor recommended” | Is the doctor independent, or are they selling the product? |
| “Research use only” | This does not mean approved for human use. |
| “Heals tendons fast” | Look for human tendon injury trials, not rat or cell studies only. |
| “No side effects” | Lack of large human studies means absence of evidence, not proof of safety. |
Bottom line
BPC-157 is one of the most talked-about experimental peptides because preclinical studies suggest possible effects on tissue repair, tendon healing, wound healing, gastrointestinal protection, and vascular repair pathways. But the human evidence is extremely limited, it is not FDA-approved, FDA has raised safety concerns around compounded BPC-157, and WADA prohibits it in competitive sport.
The most defensible conclusion is:
BPC-157 is scientifically interesting but clinically unproven for most marketed uses. Readers should be skeptical of online vendors and wellness clinics that present it as a proven healing, recovery, or anti-aging treatment.
FAQ
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide, also called Body Protection Compound-157 or stable gastric pentadecapeptide BPC 157. It has been studied mostly in animal and laboratory models for tissue repair, wound healing, tendon healing, ligament healing, and gastrointestinal protection.
What does BPC-157 do?
In preclinical studies, BPC-157 has been investigated for effects on tissue repair, tendon fibroblast migration, wound healing, gastrointestinal protection, blood-vessel-related repair, and nitric oxide signaling. These mechanisms do not prove that it works as a human therapy.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for human therapeutic use. FDA has raised safety concerns related to limited human safety data, immunogenicity, peptide impurities, and API characterization concerns.
Is BPC-157 safe?
BPC-157 does not have enough high-quality human safety data to call it safe. A tiny 2025 pilot study in 2 healthy adults reported no adverse effects from intravenous infusion, but FDA still says it lacks sufficient information to know whether BPC-157 would cause harm when administered to humans.
Does BPC-157 work?
BPC-157 shows promising effects in animal and laboratory studies, especially around tissue repair and gastrointestinal protection. But it has not been proven in large, controlled human trials for injury recovery, tendon repair, gut healing, anti-aging, or performance enhancement.
Is BPC-157 legal?
BPC-157 is not an FDA-approved drug, food, or dietary supplement ingredient in the United States. USADA has stated that there appears to be no legal basis for selling BPC-157 as a drug, food, or dietary supplement.
Is BPC-157 banned in sports?
Yes. BPC-157 is prohibited under the WADA S0 Unapproved Substances category. USADA also warns athletes that BPC-157 is prohibited and not approved for human clinical use by any global regulatory authority.
Why do sellers call BPC-157 “research use only”?
Sellers often use “research use only” language because BPC-157 is not FDA-approved for human therapeutic use. The phrase does not mean the product is safe, clinically proven, or legal for consumer medical use.
Is BPC-157 the same as TB-500?
No. BPC-157 and TB-500 are different peptides. Both are commonly marketed for injury recovery and tissue repair, but they have different origins, mechanisms, and regulatory issues.
What is the biggest risk with BPC-157?
The biggest risk is uncertainty: limited human data, unknown long-term safety, unclear dosing, product-quality problems, and regulatory concerns. FDA specifically highlights limited safety information and peptide-related impurity concerns for compounded BPC-157.
Sources
Frequently asked questions
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide studied mostly in animal and laboratory models for tissue repair, wound healing, tendon healing, ligament healing, and gastrointestinal protection.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for human therapeutic use. FDA has raised safety concerns related to limited human safety data, immunogenicity, peptide impurities, and API characterization.
Is BPC-157 safe?
BPC-157 does not have enough high-quality human safety data to call it safe. Human evidence remains extremely limited.
Is BPC-157 banned in sports?
Yes. BPC-157 is prohibited under WADA's S0 Unapproved Substances category.
Why do sellers call BPC-157 research use only?
Sellers often use research-use-only language because BPC-157 is not FDA-approved for human therapeutic use. The phrase does not mean the product is safe, clinically proven, or legal for consumer medical use.
Sources
- [1]
- [2]USADA: BPC-157, A Prohibited Peptide
Anti Doping
- [3]WADA: 2022 Prohibited List Now in Force
Anti Doping
- [4]
- [5]OPSS: BPC-157 Prohibited Peptide and Unapproved Drug
Regulatory Summary
Last updated May 9, 2026